Hoya Corporation · TSE:7741
Hoya — Q2 2022 Earnings Presentation
13 slides from Hoya's earnings presentation, Oct 30, 2022
Slide 1: HOYA Corporation Q2 FY2022 Earnings Presentation
HOYA Corporation Q2 FY2022 Earnings Presentation October 27, 2022 © 2022 HOYA CORPORATION All Rights Reserved
Slide 2: Forward Looking Statement
Forward Looking Statement HOYA may make comments and disclose information which include forward-looking statements with respect to HOYA’s plans and future performance. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements and are bas
Slide 3: Key Takeaways
Key Takeaways 1. Record quarterly sales and pretax profit amid a challenging global external environment 2. Life Care business maintained momentum: all major products achieved sales growth 3. In the Information Technology business, although the shrinkage of HDD substrates increased and imaging sales
Slide 4: Financial Overview
Financial Overview (\bn) Q2 FY21 Q1 FY22 Q2 FY22 YoY QoQ Revenue 162.6 180.2 184.1 +13% +2% Pretax Profit 54.0 61.5 61.8 +15% +0% Net Profit 43.0 48.4 47.3 +10% -2% Cf. Operating Profit 49.2 54.2 53.9 +9% -1% Cf. Operating Profit 30.3% 30.1% 29.2% -1.1ppt -0.9ppt Margin • Due to the depreciation of
Slide 5: Life Care
Life Care (\bn) Q2 FY21 Q1 FY22 Q2 FY22 YoY QoQ Revenue 99.1 110.8 118.8 +20% +7% Pretax Profit 23.4 25.0 27.4 +17% +10% Cf. Operating Profit 19.8 21.6 23.2 +17% +7% Cf. Operating Profit 19.9% 19.5% 19.5% -0.4ppt +0.0% Margin • Constant currency basis: Revenue +10%; PTP +9% 5 © 2022 HOYA CORPORATION
Slide 6: Life Care: Revenue by Product (Constant Currency Basis)
Life Care: Revenue by Product (Constant Currency Basis) Health Care Medical Endoscopes [YoY +2%] \108.7 108.7 bn Steady sales in Asia and Europe, but impact of component shortages continued \99.1 99.1 bn IOLs [YoY +15%] 27.6 Japan recovered to pre-Covid levels, resulting in overall growth 25.5 Artif
Slide 7: Information Technology (IT)
Information Technology (IT) (\bn) Q2 FY21 Q1 FY22 Q2 FY22 YoY QoQ Revenue 62.0 68.3 64.2 +4% -6% Pretax Profit 31.0 35.6 34.4 +11% -3% Cf. Operating Profit 30.1 33.5 31.7 +5% -6% Cf. Operating Profit 48.6% 49.1% 49.3% +0.7ppt +0.2ppt Margin • Constant currency basis: Revenue -7%; PTP +0% 7 © 2022 HO
Slide 8: IT: Revenue by Product (Constant Currency Basis)
IT: Revenue by Product (Constant Currency Basis) Electronics Imaging \62.0bn 62.0 Imaging [YoY-19%] \57.7 57.7 bn Decrease due to zero-Covid policy in China and economic slowdown in the U.S. and Europe 10.2 8.3 Masks & Blanks [YoY +17%] LSI Continued strong performance of EUV blanks due to aggressiv
Slide 9: Highlights from the Balance Sheet & Cash Flow
Highlights from the Balance Sheet & Cash Flow Shareholder Return • Completed 60 bn yen share buyback on October 20 • At today's BOD meeting, the Company resolved to cancel all shares repurchased (1.15% of shares outstanding) CAPEX * • Result in Q2: 6.3 bn yen (YoY \-0.3 bn) • Annual FY22 is expected
Slide 10: Contact Lens Private Brand (PB)
Contact Lens Private Brand (PB) • Previously, the Company's contact lens business was focused on retail sales, and sales of its own products were extremely small. • In order to differentiate ourselves from competing retailers and increase customer retention, we launched two PB products in March of t
Slide 11: Launch of hoyaONE treasured
Launch of hoyaONE treasured • hoyaONE treasured", a PB product manufactured at our own factory, is scheduled to be released in December of this year. • It has high oxygen permeability and collects moisture on the lens surface, resulting in a soft and comfortable wearing feeling. • Transitioning to a
Slide 12: Notes
Notes ✓ Accounting standard: IFRS ✓ The fiscal year ending March 2023 is referred to as “FY22” throughout this document. ✓ Figures less than 100 million yen are rounded down. Accordingly, some discrepancies may occur among totals. Ratios are calculated using actual numbers. ✓ Operating profit is cal
Slide 13: Innovating For a Better Tomorrow
Innovating For a Better Tomorrow